11 – 20 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
IL-33 drives influenza-induced asthma exacerbations by halting innate and adaptive antiviral immunity
- Contribution to journal › Article
-
Mark
The SQ tree SLIT-tablet is highly effective and well tolerated : Results from a randomized, double-blind, placebo-controlled phase III trial
- Contribution to journal › Article
-
Mark
IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation
- Contribution to journal › Article
- 2018
-
Mark
Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass : A randomized, double-blind, placebo-controlled trial
- Contribution to journal › Letter
-
Mark
Viral induced overproduction of epithelial TSLP : Role in exacerbations of asthma and COPD?
- Contribution to journal › Debate/Note/Editorial
-
Mark
Substance P represents a novel first-line defense mechanism in the nose
- Contribution to journal › Article
-
Mark
Lytic eosinophils produce extracellular DNA traps as well as free eosinophil granules
- Contribution to journal › Debate/Note/Editorial
-
Mark
Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations : A randomized controlled study
- Contribution to journal › Article
- 2017
-
Mark
Antibody-encoding repertoires of bone marrow and peripheral blood-a focus on IgE
- Contribution to journal › Letter
-
Mark
Epithelial perviousness in allergic airways disease
- Contribution to journal › Debate/Note/Editorial
